Century Therapeutics (NASDAQ:IPSC) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.17) by 31.25 percent. This is a 112.36 percent decrease over earnings of $0.89 per share from the same period last year.